Jody Kamminga
Overview
Explore the profile of Jody Kamminga including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
287
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Screening Tools for Cognitive Impairment in Adults with Substance Use Disorders: A Systematic Review
Ko K, Ridley N, Bryce S, Allott K, Smith A, Kamminga J
J Int Neuropsychol Soc
. 2021 Aug;
28(7):756-779.
PMID: 34433502
Objectives: Cognitive impairment is common in individuals with substance use disorders (SUDs), yet no evidence-based guidelines exist regarding the most appropriate screening measure for use in this population. This systematic...
2.
Gates T, Kamminga J, Jayewardene A, Vincent T, Quan D, Brew B, et al.
Arch Clin Neuropsychol
. 2020 Dec;
36(5):859.
PMID: 33367511
No abstract available.
3.
Gates T, Kamminga J, Jayewardene A, Vincent T, Quan D, Brew B, et al.
Arch Clin Neuropsychol
. 2020 Oct;
36(4):597-612.
PMID: 33037817
Objective: To compare the performance of four reliable change (RC) methods with respect to measuring cognitive change on the Cogstate Computerized Battery (CCB). Method: We assessed cognitive change in 57...
4.
Kamminga J, Lal L, Wright E, Bloch M, Brew B, Cysique L
Curr HIV/AIDS Rep
. 2017 Mar;
14(3):83-92.
PMID: 28284004
Screening tools to identify HIV-associated neurocognitive disorder (HAND) are primarily devised to detect cognitive impairment on a single occasion. With the chronicity of HIV infection and the risk of HAND...
5.
Kamminga J, Bloch M, Vincent T, Carberry A, Brew B, Cysique L
J Clin Exp Neuropsychol
. 2017 Jan;
39(8):753-767.
PMID: 28052738
Introduction: The current study sought to determine the optimal impairment rating definition for a new HIV-associated neurocognitive disorder (HAND) screening procedure as compared to standard neuropsychological testing. Method: A total...
6.
Bloch M, Kamminga J, Jayewardene A, Bailey M, Carberry A, Vincent T, et al.
Clin Infect Dis
. 2016 Jun;
63(5):687-693.
PMID: 27325690
Background: Human immunodeficiency virus (HIV)-associated neurocognitive disorders (HAND) are not routinely assessed due to the lack of an adequate screening strategy. We aimed to develop a clinically relevant screening procedure...
7.
Kamminga J, Leslie F, Hsieh S, Caga J, Mioshi E, Hornberger M, et al.
Neurobiol Aging
. 2016 Apr;
41:11-18.
PMID: 27103514
To establish the frequency, severity, relationship to bulbar symptoms, and neural correlates of syntactic comprehension deficits across the frontotemporal dementia-amyotrophic lateral sclerosis (FTD-ALS) disease spectrum. In total, 85 participants were...
8.
Irish M, Bunk S, Tu S, Kamminga J, Hodges J, Hornberger M, et al.
Neuropsychologia
. 2015 Dec;
81:50-60.
PMID: 26683384
Episodic memory impairment represents one of the hallmark clinical features of patients with Alzheimer's disease (AD) attributable to the degeneration of medial temporal and parietal regions of the brain. In...
9.
Irish M, Halena S, Kamminga J, Tu S, Hornberger M, Hodges J
Cortex
. 2015 Sep;
73:10-23.
PMID: 26343342
Episodic memory dysfunction represents one of the most prominent and characteristic clinical features of patients with Alzheimer's disease (AD), attributable to the degeneration of medial temporal and posterior parietal regions...
10.
Irish M, Kamminga J, Addis D, Crain S, Thornton R, Hodges J, et al.
J Neuropsychol
. 2015 May;
10(2):295-316.
PMID: 26014271
Compromised retrieval of autobiographical memory (ABM) is well established in neurodegenerative disorders. The recounting of autobiographical events is inextricably linked to linguistic knowledge, yet no study to date has investigated...